true
--12-31
0001695473
0001695473
2025-10-15
2025-10-15
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K/A
Amendment
No. 1
CURRENT
REPORT
Pursuant
to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): October 15, 2025
| The
Greater Cannabis Company Inc. |
| (Exact
name of registrant as specified in charter) |
| Florida |
|
000-56027 |
|
30-0842570 |
(State
or other Jurisdiction
of Incorporation) |
|
(Commission
File Number) |
|
(IRS
Employer
Identification No.) |
| 15
Walker Ave, Suite 101, Baltimore, MD |
|
21208 |
| (Address
of Principal Executive Offices) |
|
(Zip
Code) |
Registrant’s
telephone number, including area code: (443)-738-4051
| |
| (Former
name or former address, if changed since last report) |
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of Company under any of
the following provisions:
| ☐ |
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
|
| ☐ |
Soliciting
material pursuant to Rule 14a-12(b) under the Exchange Act (17 CFR 240.14a-12(b)) |
| |
|
| ☐ |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
|
| ☐ |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities
registered pursuant to Section 12(b) of the Act:
| Title
of each class |
|
Trading
Symbol(s) |
|
Name
of each exchange on which registered |
| None |
|
GCAN |
|
None |
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405)
or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging
growth company ☐
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
As
used in this Current Report on Form 8-K (this “Current Report”), and unless otherwise indicated, the terms “the
Company,” “GCAN,” “we,” “us” and “our” refer to
The Greater Cannabis Company, Inc. and its subsidiaries.
Explanatory
Note
Due
to an administrative oversight, the reverse stock split previously reported in our Current Report on Form 8-K filed with the Securities
and Exchange Commission on October 15, 2025 (the “Original Report”), was omitted from the FINRA Daily List on that
date. Accordingly, the effective and post-reverse split trading dates of our reverse stock split were delayed by one day. We are hereby
amending the Original Report to provide the updated dates as set forth below.
Item
5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
The
disclosure set forth in Item 8.01 of this Current Report on Form 8-K is incorporated into this item by reference.
Item
8.01 Other Matters.
Reverse
Stock Split
We
are implementing a 1-for-1,500 reverse split of the Company’s common stock (the “Reverse Split”) effective as of the
close of business on October 16, 2025. As a result, every 1,500 pre-Reverse Split shares of common stock outstanding will automatically
combine into one new share of post-Reverse Split common stock without any action on the part of the holders.
The
Company’s common stock will begin trading on a post-Reverse Split basis at the opening of trading on Friday, October 17, 2025.
In connection therewith, the Company’s ticker symbol will be GCAND for twenty (20) trading days to designate that it is trading
on a post-Reverse Split basis. In addition, our post-Reverse Split common stock will trade under the new CUSIP Number 391657202.
Following
the Reverse Split, the number of shares of the Company’s issued and outstanding common stock will have been reduced from 1,349,888,436
to approximately 900,256. The Reverse Split will also apply to shares of common stock issuable upon the conversion of outstanding convertible
debt, warrants and stock options. No fractional shares of common stock will be issued as a result of the reverse stock split. Instead,
the Company will issue one whole share of the post-reverse stock split common stock to any stockholder who otherwise would have received
a fractional share as a result of the reverse stock split. The number of authorized common stock shall remain unaffected and the par
value shall remain at $0.001 per share.
There
is not a requirement that stockholders obtain new or replacement share certificates. Each of the holders of record of shares of the Company’s
common stock that is outstanding on the effective date of the reverse stock split may contact the Company’s transfer agent to exchange
the certificates for new certificates representing the number of whole shares of post-reverse stock split common stock into which the
existing shares of common stock have been converted as a result of the reverse stock split.
Upon
the completion of the reverse stock split, the Company will have additional shares of common stock available for issuance. Although the
Company may use the additional authorized shares of common stock in the future to raise additional capital, it has no specific plans,
arrangements, or understandings to do so beyond making shares available for issuance pursuant to the conversion of outstanding convertible
debt and the exercise of outstanding options and warrants, if applicable.
In
connection with the reverse stock split, we filed Articles of Amendment to our Articles of Incorporation with the Secretary of State
of Florida, a copy of which is included as Exhibit 3.1 to this Report.
The
Company expects that shareholders holding GCAN shares at registered brokerage firms or at the transfer agent will have the Reverse Split
transaction processed automatically in their accounts over the next few days. Shareholders holding physical stock certificates may request
new certificates evidencing their post-Reverse Split shares by contacting the Company’s transfer agent, ClearTust, LLC, 16540 Pointe
Village Dr, Suite 210, Lutz, Florida 33558, cleartrustonline.com or (813) 235-4490.
Item
9.01 Financial Statements and Exhibits.
| Exhibit
Number |
|
Description |
| 3.1(*) |
|
Articles of Amendment to Articles of Incorporation of The Greater Cannabis Company, Inc. |
| |
|
|
| 104 |
|
Cover
Page Interactive Data File (embedded within the Inline XBRL document) |
(*)
Filed as an exhibit to the Company’s Current Report on Form 8-K filed on October 15, 2025 and incorporated herein by reference.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
| Dated:
October 16, 2025 |
THE
GREATER CANNABIS COMPANY INC. |
| |
|
|
| |
By: |
/s/
Aitan Zacharin |
| |
|
Aitan
Zacharin
Chief
Executive Officer |
